
226: Pharma's telehealth gold mine, the return of the biotech IPO, & a merger deferred
The Readout Loud
00:00
Is Direct-to-Consumer Telehealth Driving Prescription Drugs?
This comes amid increased scrutiny for direct-to-consumer telehealth prescribers. Policy experts worry that it'll erode the doctor-patient relationship and lead to poor care overall. If this kind of ad-length telehealth disproportionately drives scripts for expensive drugs, "it could increase overall healthcare costs"
Transcript
Play full episode